Abstract
Abstract
Background
The objective was to compare sevoflurane, a volatile sedation agent with potential bronchodilatory properties, with propofol on respiratory mechanics in critically ill patients with COPD exacerbation.
Methods
Prospective study in an ICU enrolling critically ill intubated patients with severe COPD exacerbation and comparing propofol and sevoflurane after 1:1 randomisation. Respiratory system mechanics (airway resistance, PEEPi, trapped volume, ventilatory ratio and respiratory system compliance), gas exchange, vitals, safety and outcome were measured at inclusion and then until H48. Total airway resistance change from baseline to H48 in both sevoflurane and propofol groups was the main endpoint.
Results
Sixteen patients were enrolled and were sedated for 126 h(61–228) in the propofol group and 207 h(171–216) in the sevoflurane group. At baseline, airway resistance was 21.6cmH2O/l/s(19.8–21.6) in the propofol group and 20.4cmH2O/l/s(18.6–26.4) in the sevoflurane group, (p = 0.73); trapped volume was 260 ml(176–290) in the propofol group and 73 ml(35–126) in the sevoflurane group, p = 0.02. Intrinsic PEEP was 1.5cmH2O(1–3) in both groups after external PEEP optimization. There was neither early (H4) or late (H48) significant difference in airway resistance and respiratory mechanics parameters between the two groups.
Conclusions
In critically ill patients intubated with COPD exacerbation, there was no significant difference in respiratory mechanics between sevoflurane and propofol from inclusion to H4 and H48.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Global initiative for chronic obstructive lung disease. Global strategy for chronic obstructive lung disease. Global strategy for prevention, diagnosis and management of COPD 2023 Report [Internet]. https://goldcopd.org/2023-gold-report-2/.
2. O’Donnell DE. COPD exacerbations {middle dot} 3: pathophysiology. Thorax. 2006;61:354–61.
3. Junhasavasdikul D, Telias I, Grieco DL, Chen L, Gutierrez CM, Piraino T, et al. Expiratory Flow Limitation during Mechanical Ventilation. Chest. 2018;154:948–62.
4. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–46.
5. Dres M, Tran T-C, Aegerter P, Rabbat A, Guidet B, Huchon G, et al. Influence of ICU case-volume on the management and hospital outcomes of Acute exacerbations of Chronic Obstructive Pulmonary Disease*. Crit Care Med. 2013;41:1884–92.